Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Kardigan itching for IPO to fund late-stage cardio pipeline
Kardigan may have only launched last year, but it seems the cardiovascular-focused biotech is already eyeing the public markets.
James Waldron
May 27, 2026 4:57am
Parabilis, fresh from inking Regeneron pact, plans IPO
May 20, 2026 5:25am
Odyssey CEO sees $304M IPO creating ‘little large pharma’
May 8, 2026 7:27am
Seaport CEO's 'rationale behind going public' via $255M IPO
May 1, 2026 12:30pm
Avalyn brings in $300M from oversized IPO
Apr 30, 2026 3:18am
Seaport, Hemab chart courses for $180M IPOs this week
Apr 27, 2026 12:29pm
